Login
$CTTH
$0.05 -$0.00 (3.06%) Close

Insider Transactions

What CTT Pharmaceutical Holdings Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 16 20
Sells 0 0
Total trades 16 20

Shares traded

3 months 12 months
Acquired 0 0
Disposed 0 0
Net activity +0 +0

Common stock only — 20 reported trades in the last 12 months are in a security these totals do not cover.

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Ctt Pharmaceutical HOLDINGS, Inc. CEO Oct 26 Open-market buy · P +5,880 $0.06 +$335 9,442,536
Ctt Pharmaceutical HOLDINGS, Inc. CEO Oct 15 Open-market buy · P +2,000 $0.06 +$114 9,436,656
Ctt Pharmaceutical HOLDINGS, Inc. CEO Oct 06 Open-market buy · P +3,700 $0.06 +$204 9,433,656
Ctt Pharmaceutical HOLDINGS, Inc. CEO Sep 28 Open-market buy · P +3,400 $0.06 +$187 9,429,956
Ctt Pharmaceutical HOLDINGS, Inc. CEO Sep 22 Open-market buy · P +10,100 $0.05 +$455 9,424,556
Ctt Pharmaceutical HOLDINGS, Inc. CEO Sep 22 Open-market buy · P +10,100 $0.05 +$455 1,056,800
Ctt Pharmaceutical HOLDINGS, Inc. CEO Sep 16 Open-market buy · P +10,900 $0.05 +$523 9,414,456
Ctt Pharmaceutical HOLDINGS, Inc. CEO Sep 10 Open-market buy · P +3,500 $0.05 +$175 9,400,556
Ctt Pharmaceutical HOLDINGS, Inc. CEO Sep 04 Open-market buy · P +9,800 $0.05 +$479 9,397,056
Ctt Pharmaceutical HOLDINGS, Inc. CEO Sep 02 Open-market buy · P +3,000 $0.05 +$147 9,387,256
Ctt Pharmaceutical HOLDINGS, Inc. CEO Aug 31 Open-market buy · P +3,500 $0.05 +$172 9,384,256
Ctt Pharmaceutical HOLDINGS, Inc. CEO Aug 24 Open-market buy · P +2,100 $0.06 +$116 9,360,756
Ctt Pharmaceutical HOLDINGS, Inc. CEO Aug 20 Open-market buy · P +11,500 $0.05 +$518 9,378,656
Ctt Pharmaceutical HOLDINGS, Inc. CEO Aug 19 Open-market buy · P +10,000 $0.06 +$590 9,365,456
Ctt Pharmaceutical HOLDINGS, Inc. CEO Aug 14 Open-market buy · P +1,800 $0.06 +$112 9,355,456
Ctt Pharmaceutical HOLDINGS, Inc. CEO Aug 07 Open-market buy · P +7,700 $0.07 +$501 9,353,656
Ctt Pharmaceutical HOLDINGS, Inc. CEO Dec 17 Open-market buy · P +8,300 $0.06 +$457 7,845,956
Ctt Pharmaceutical HOLDINGS, Inc. CEO Nov 20 Open-market buy · P +62,900 $0.04 +$2.52K 7,837,656
Ctt Pharmaceutical HOLDINGS, Inc. Director Nov 20 Open-market buy · P +200,000 $0.04 +$8K 3,734,003
Ctt Pharmaceutical HOLDINGS, Inc. CEO Oct 31 Open-market buy · P +7,000 $0.06 +$420 7,774,756

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support